Merimna Pharma India Private Limited
About Merimna Pharma India Private Limited
Data last updated:
Merimna Pharma India Private Limited is a private limited company based in Nilambur, Kerala, India. It was incorporated on 26 May 2023.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U47721KL2023PTC081640.
The company has an authorised share capital of ₹36 Lakh and a paid-up capital of ₹32.5 Lakh. It is led by directors including Sunil Uralath (Managing Director) and Vinu Poonoth.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nilambur, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹52.16 Lakh, a growth of 118% compared to the previous year. For the same year it recorded a net loss of ₹15.18 Lakh (net margin -29.1%) and EBITDA of -₹15.19 Lakh (EBITDA margin -29.1%).
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Company details
Contact details
Merimna Pharma India Private Limited's registered office is in Nilambur, Kerala.
- Registered Address20/577 A, Elankur Road Ernad, Nilambur, Kerala, India – 676123
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Merimna Pharma India is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Merimna Pharma India Private Limited, buy the company report.
Financials of Merimna Pharma India Private Limited
FY 2025 filings availableMerimna Pharma India Private Limited reported revenue of ₹52.16 Lakh (up 118% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 118% in the latest year. EBITDA fell 129% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹15.19 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹15.18 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -29.1% | |
| Net Profit Margin | -29.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Merimna Pharma India Private Limited, buy the company report.
Board of directors of Merimna Pharma India Private Limited
Merimna Pharma India has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinu Poonoth | Director | 13 Nov 2023 | 3 Years 0 Months | Current |
| Balasubramanian | Director | 13 Nov 2023 | 3 Years 0 Months | Current |
| Nambrath Mahesh | Director | 13 Nov 2023 | 3 Years 0 Months | Current |
| Sunil Uralath | Managing Director | 26 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Merimna Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lalvin Pharma Private Limited | ₹52.4 Lakh (FY 2025) | 44.0% | Hyderabad, Telangana, India | |||
| Rising Star Elevator Private Limited | ₹52.29 Lakh (FY 2024) | -24.0% | New Delhi, Delhi, India | |||
| Werise Pharmaceutical Private Limited | ₹52.28 Lakh (FY 2025) | 116.0% | Gurgaon, Haryana, India | |||
| Luxe Lounge Private Limited | ₹52.22 Lakh (FY 2025) | 183.0% | Rajkot, Gujarat, India | |||
| Fluidcube Technologies Private Limited | ₹52.2 Lakh (FY 2024) | Pune, Maharashtra, India | ||||
| Merimna Pharma India Private Limitedthis company | ₹52.16 Lakh (FY 2025) | -₹15.18 Lakh | -29.1% | 118.0% | Nilambur, Kerala, India | |
| Molytron Synthetics Private Limited | ₹52.13 Lakh (FY 2025) | -55.0% | Silvassa, Dadra and Nagar Haveli, India | |||
| Kioski Dealers Private Limited | ₹52.09 Lakh (FY 2025) | 19.0% | Kolkata, West Bengal, India | |||
| Medizone Biotech Private Limited | ₹52.09 Lakh (FY 2025) | 15.0% | Delhi, India | |||
| Trupti Multitrade Private Limited | ₹52.08 Lakh (FY 2025) | 33.0% | Mumbai, Maharashtra, India | |||
| Akshraj Pharmaceuticals Private Limited | ₹52.01 Lakh (FY 2025) | 295.0% | Ambala, Haryana, India |
To see the full peer comparison of Merimna Pharma India Private Limited, buy the company report.
Legal cases
Merimna Pharma India Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Abbott Product Operations Ag & Anr. | Pending |
To see the full case history of Merimna Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Merimna Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Merimna Pharma India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Merimna Pharma India Private Limited has 6 board changes on record since 2023: 5 appointments and 1 cessation. The latest: Balasubramanian was appointed as Director on 13 Nov 2023.
Frequently asked questions
Merimna Pharma India is an active private limited company based in Nilambur, Kerala, India. It was incorporated on 26 May 2023 (3+ years old) and is registered under CIN U47721KL2023PTC081640.
Merimna Pharma India has 4 current directors:
- Sunil Uralath - Managing Director
- Vinu Poonoth - Director
- Balasubramanian - Director
- Nambrath Mahesh - Director
The latest financial statements of Merimna Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Merimna Pharma India is U47721KL2023PTC081640. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Merimna Pharma India has 1 court case on record: 1 filed against it. 1 is pending.
Merimna Pharma India was incorporated on 26 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Merimna Pharma India by revenue are Lalvin Pharma Private Limited, Rising Star Elevator Private Limited, Werise Pharmaceutical Private Limited, Luxe Lounge Private Limited, Fluidcube Technologies Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Balasubramanian was appointed as Director on 13 Nov 2023. Nambrath Mahesh was appointed as Director on 13 Nov 2023. Sourav Krishnan ceased to be Director on 13 Nov 2023. Merimna Pharma India has 6 board changes on record in total.
The registered office of Merimna Pharma India is at 20577 A, Elankur Road Ernad, Nilambur, Kerala, India – 676123.
Merimna Pharma India can be reached at its registered office: 20577 A, Elankur Road Ernad, Nilambur, Kerala, India – 676123.
Merimna Pharma India is registered under the jurisdiction of the Registrar of Companies (ROC), Ernakulam.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
